Summary:
- Alibaba's AI-powered cancer detection tool has received approval from the U.S. Food and Drug Administration (FDA) for a faster approval process.
- The tool uses artificial intelligence to analyze medical images and detect signs of lung cancer, potentially helping doctors make quicker diagnoses.
- This FDA approval marks a significant milestone for Alibaba's healthcare technology and could pave the way for more AI-based medical tools to be approved and used in the future.